Multiple A-share companies reveal progress and product dynamics in brain-computer interface technology.

In recent performance briefings and investor relations activities, more than 10 A-share listed companies such as Xiangyu Medical, Mailande, Botu Biology, and Shangji Technology have disclosed the latest developments in the brain-computer interface business. Some companies expect the brain-computer interface business to contribute to revenue within the year, some say they will soon launch multiple new products, and others will seize development opportunities through investment layout. Looking ahead to the second half of the year, A-share listed companies related to brain-computer interfaces will further accelerate investment and product implementation. Local policies are also stepping up efforts, clearing commercial barriers by adding medical service price items, and promoting the domestic brain-computer interface industry to enter a new stage of "technological breakthrough + commercial implementation" driven by dual wheels.